Cingulate Inc.
Cingulate Inc. (CING) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · CING · as of Sep 30, 2025
Ownership Breakdown
12
Institutional Holders
▼ 3 vs Q2
$1.14M
Total Inst. Value
▼ $43,411 vs Q2
5.61M
Shares Outstanding
freeFloat 99.84%
290,328
13F Shares Held
▲ 113 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
CING largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
KESTRA ADVISORY SERVICES, LLC pharmaceutical preparations | 94.0K | 1.73% | 1.73% | $368.56M | Nov 14, 2025 | NEW |
VANGUARD GROUP INC pharmaceutical preparations | 73.8K | 1.36% | 1.36% | $289.28M | Nov 7, 2025 | ▲ 38.4K |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 42.4K | 78.08% | 78.08% | $166.23M | Nov 12, 2025 | ▲ 10.3K |
QUANTUM PRIVATE WEALTH, LLC pharmaceutical preparations | 24.0K | 44.19% | 44.19% | $94.08M | Nov 10, 2025 | ▲ 14.0K |
LPL FINANCIAL LLC pharmaceutical preparations | 20.3K | 37.28% | 37.28% | $79.38M | Nov 12, 2025 | ▲ 8.1K |
NORTHERN TRUST CORP pharmaceutical preparations | 13.4K | 24.64% | 24.64% | $52.47M | Nov 14, 2025 | NEW |
VIRTU FINANCIAL LLC pharmaceutical preparations | 10.8K | 19.83% | 19.83% | $42.00M | Nov 14, 2025 | ▼ 2.6K |
BANK OF AMERICA CORP /DE/ pharmaceutical preparations | 7.5K | 13.73% | 13.73% | $29.22M | Feb 3, 2026 | ▼ 46 |
HARBOUR INVESTMENTS, INC. pharmaceutical preparations | 2.3K | 4.19% | 4.19% | $8.92M | Nov 12, 2025 | NEW |
UBS GROUP AG pharmaceutical preparations | 1.3K | 2.39% | 2.39% | $5.09M | Nov 13, 2025 | ▼ 11.3K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
5
Increased
+71.4K shares3
New Positions
first time holders4
Decreased
−14.2K shares6
Sold Out
fully exitedNet shares change (top 50)
+57.1K
+71.4K / −14.2K
Net new holders
-2
3 new / 6 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
CING insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
13
Buy transactions
5
Sell transactions
2.60
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Hargroves Thomas Jeffrey director | Feb 13, 2026 | Purchase | 97,276 | $5.04 | $490.3K | 97.5K | Form 4 ↗ |
Hargroves Thomas Jeffrey director | Feb 13, 2026 | Purchase | 77,821 | $5.04 | $392.2K | 77.8K | Form 4 ↗ |
Hargroves Thomas Jeffrey director | Mar 9, 2026 | Award | 15,000 | $6.85 | $102.8K | 15.0K | Form 4 ↗ |
Silva Raul R. EVP and CSO | Mar 31, 2026 | Award | 3,422 | $6.21 | $21.3K | 3.422 | Form 4 ↗ |
Silva Raul R. EVP and CSO | Mar 9, 2026 | Award | 4,526 | — | — | 6.5K | Form 4 ↗ |
Silva Raul R. EVP and CSO | Mar 9, 2026 | Tax Withhold | 1,828 | — | — | 4.6K | Form 4 ↗ |
Schaffer Shane J. Chief Executive Officer | Mar 9, 2026 | Award | 6,862 | — | — | 7.0K | Form 4 ↗ |
Schaffer Shane J. Chief Executive Officer | Mar 9, 2026 | Tax Withhold | 2,959 | — | — | 4.1K | Form 4 ↗ |
Callahan Jennifer L. EVP and CFO | Mar 9, 2026 | Award | 15,329 | — | — | 20.4K | Form 4 ↗ |
Callahan Jennifer L. EVP and CFO | Mar 9, 2026 | Tax Withhold | 6,427 | — | — | 14.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Cingulate Inc. (CING) is primarily owned by institutional investors, who hold approximately 5.2% of total shares outstanding. Company insiders own approximately 0.16%, while retail and public investors account for the remaining 94.66%.
The largest institutional shareholder of Cingulate Inc. is KESTRA ADVISORY SERVICES, LLC, holding approximately 94,021 shares — equal to 1.73% of outstanding shares — as of September 30, 2025.
A total of 12 institutional investors currently hold CING stock, with a combined institutional value of approximately $1,137,900 as of the most recent 13F filing period.
Frequently asked questions
CING ownershipCingulate Inc. (CING) is primarily owned by institutional investors, who hold approximately 5.2% of shares. The largest shareholder is KESTRA ADVISORY SERVICES, LLC with a 1.73% stake. Company insiders hold 0.16%. Data sourced from SEC Form 13F as of September 30, 2025.